Unilever PLC - Research & Development Agrmnt
1998年10月6日 - 11:00PM
RNSを含む英国規制内ニュース (英語)
RNS No 9738x
UNILEVER PLC
UNILEVER NV
6th October 1998
UNILEVER LICENSES HAIR RESEARCH TO BRISTOL-MYERS SQUIBB
Unilever and Bristol-Myers Squibb Company (6 October)
announced a research and development agreement in the area of
hair-loss prevention. According to the companies, Bristol-
Myers Squibb will obtain the rights to hair follicle research
and patents developed by Unilever. Financial details were not
disclosed.
Unilever will receive milestone payments as Bristol-Myers
Squibb develops prescription compounds that will be used to
prevent hair loss. The companies also may collaborate on
development of over-the-counter products in the future.
"This is the first time that a technology from a Unilever
research program will be licensed to a pharmaceutical company
for the expressed purpose of developing a prescription
product," said Dr. Lincoln Krochmal, Unilever's Senior Vice
President, Home & Personal Care Research. "This ground-
breaking agreement, with Bristol-Myers Squibb not only gives
them access to proven scientific technology, but provides
Unilever with potential commercialization of a technology
which was not being advanced to the marketplace."
"Bristol-Myers Squibb is a recognized industry leader in
bringing effective therapies to the market," said Milton E.
Goggans, President, Westwood-Squibb. "We're pleased to have
this opportunity to add Unilever's research to our dermatology
discovery portfolio."
END
MSCANOOKWUKRRAA
Unilever Nv (LSE:UNV)
過去 株価チャート
から 8 2024 まで 9 2024
Unilever Nv (LSE:UNV)
過去 株価チャート
から 9 2023 まで 9 2024
Real-Time news about Unilever Nv (ロンドン証券取引所): 0 recent articles
その他のUnilever Nv.ニュース記事